What Are Some Of The Key Challenges Pharma Has Faced In 2022? Will These Continue Into 2023?

As 2023 takes over, there is a lot of hope that makes us cling to the pharmaceutical sector: a hope of getting novel ideas to work, a hope to embrace more technology, and a hope to fill the gap.

3 Life Sciences Innovation Factors To Watch Out For In 2023

In order to stay ahead of the curve, 2023 will be all about re-evaluating the existing life sciences practices and make use of innovation wherever necessary.

4 Factors That Pharma Supply Chains Need To Address Swiftly

Next generation innovations and technologies, clinical trials that are shortened, digitisation, all have to be looked into for better pharma supply chains.

Cancer Vaccine Redesign - A Transformation In The Making

Researchers are using nanotechnology that amend the location of adjuvant and antigen on the cancer vaccine in order to enhance its effectiveness and efficacy.

Matching Medication To DNA Leads To 30% Fewer Side Effects

A patients genetic profile gets linked to medications and once the pass gets scanned, doctors and pharmacists can zero-upon the best drug dose for treatment.

FDA Gives First RMAT Designation To A Cardiac Gene Therapy

The RMAT status for gene therapy RP-501 will help in an extensive FDA guidance and benefits and offer a quick review as far as program development is concerned.

U.K. Pharma Lobby Urges Govt. To Halt Plans To Raise Revenue Recovery Rates

The association of British Pharmaceutical Industry suggests government action against planned UK statutory clawback rate rise when it comes to branded drugs.